These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38859884)

  • 1. Clinical and Molecular Characterization of Hyperinsulinism in Kabuki Syndrome.
    Rosenfeld E; Mitteer LM; Boodhansingh K; Sanders VR; McKnight H; De Leon DD
    J Endocr Soc; 2024 May; 8(7):bvae101. PubMed ID: 38859884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative meta-analysis of Kabuki syndrome with and without hyperinsulinaemic hypoglycaemia.
    Hoermann H; El-Rifai O; Schebek M; Lodefalk M; Brusgaard K; Bachmann N; Bergmann C; Roeper M; Welters A; Salimi Dafsari R; Blankenstein O; Mayatepek E; Christesen H; Meissner T; Kummer S
    Clin Endocrinol (Oxf); 2020 Sep; 93(3):346-354. PubMed ID: 32533869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals.
    Yap KL; Johnson AEK; Fischer D; Kandikatla P; Deml J; Nelakuditi V; Halbach S; Jeha GS; Burrage LC; Bodamer O; Benavides VC; Lewis AM; Ellard S; Shah P; Cody D; Diaz A; Devarajan A; Truong L; Greeley SAW; De Leó-Crutchlow DD; Edmondson AC; Das S; Thornton P; Waggoner D; Del Gaudio D
    Genet Med; 2019 Jan; 21(1):233-242. PubMed ID: 29907798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent Hypoglycemia and Hyperinsulinism in a Patient With
    Nunez Stosic M; Gomez P
    JCEM Case Rep; 2023 Mar; 1(2):luad032. PubMed ID: 37908464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A narrative review on pathogenetic mechanisms of hyperinsulinemic hypoglycemia in Kabuki syndrome.
    Maines E; Maiorana A; Leonardi L; Piccoli G; Soffiati M; Franceschi R
    Endocr Regul; 2023 Jan; 57(1):128-137. PubMed ID: 37285460
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital hyperinsulinism and novel KDM6A duplications -resolving pathogenicity with genome and epigenetic analyses.
    Männistö JME; Hopkins JJ; Hewat TI; Nasser F; Burrage J; Dastamani A; Mirante A; Murphy N; Rzasa J; Kerkhof J; Relator R; Johnson MB; Laver TW; Weymouth L; Houghton JAL; Wakeling MN; Sadikovic B; Dempster EL; Flanagan SE
    J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39078990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel
    Salguero MV; Chan K; Greeley SAW; Dyamenahalli U; Waggoner D; Del Gaudio D; Rajiyah T; Lemelman M
    J Endocr Soc; 2022 Apr; 6(4):bvac015. PubMed ID: 35237736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rare Cause of Hyperinsulinemic Hypoglycemia: Kabuki Syndrome.
    Mısırlıgil M; Yıldız Y; Akın O; Odabaşı Güneş S; Arslan M; Ünay B
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):452-455. PubMed ID: 32830475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype.
    Usluer E; Sayın GY; Güneş N; Kasap B; Tüysüz B
    Am J Med Genet A; 2022 Oct; 188(10):2976-2987. PubMed ID: 36097644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2.
    Ferrara CT; Boodhansingh KE; Paradies E; Fiermonte G; Steinkrauss LJ; Topor LS; Quintos JB; Ganguly A; De Leon DD; Palmieri F; Stanley CA
    J Clin Endocrinol Metab; 2017 Mar; 102(3):942-949. PubMed ID: 27967291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis.
    Kawai T; Iwasaki Y; Ogata-Kawata H; Kamura H; Nakamura K; Hata K; Takano T; Nakabayashi K
    Eur J Med Genet; 2023 Aug; 66(8):104806. PubMed ID: 37379880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.
    Cheon CK; Sohn YB; Ko JM; Lee YJ; Song JS; Moon JW; Yang BK; Ha IS; Bae EJ; Jin HS; Jeong SY
    J Hum Genet; 2014 Jun; 59(6):321-5. PubMed ID: 24739679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.
    Bögershausen N; Gatinois V; Riehmer V; Kayserili H; Becker J; Thoenes M; Simsek-Kiper PÖ; Barat-Houari M; Elcioglu NH; Wieczorek D; Tinschert S; Sarrabay G; Strom TM; Fabre A; Baynam G; Sanchez E; Nürnberg G; Altunoglu U; Capri Y; Isidor B; Lacombe D; Corsini C; Cormier-Daire V; Sanlaville D; Giuliano F; Le Quan Sang KH; Kayirangwa H; Nürnberg P; Meitinger T; Boduroglu K; Zoll B; Lyonnet S; Tzschach A; Verloes A; Di Donato N; Touitou I; Netzer C; Li Y; Geneviève D; Yigit G; Wollnik B
    Hum Mutat; 2016 Sep; 37(9):847-64. PubMed ID: 27302555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.
    Yap CS; Jamuar SS; Lai AHM; Tan ES; Ng I; Ting TW; Tan EC
    Gene; 2020 Mar; 731():144360. PubMed ID: 31935506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.
    Van Laarhoven PM; Neitzel LR; Quintana AM; Geiger EA; Zackai EH; Clouthier DE; Artinger KB; Ming JE; Shaikh TH
    Hum Mol Genet; 2015 Aug; 24(15):4443-53. PubMed ID: 25972376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kabuki syndrome: clinical and molecular characteristics.
    Cheon CK; Ko JM
    Korean J Pediatr; 2015 Sep; 58(9):317-24. PubMed ID: 26512256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Lanreotide in the Treatment of Congenital Hyperinsulinism.
    Cuff H; Lord K; Ballester L; Scully T; Stewart N; De Leon DD
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3115-e3120. PubMed ID: 35587448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel
    Guo HX; Li BW; Hu M; Si SY; Feng K
    World J Clin Cases; 2021 Nov; 9(33):10257-10264. PubMed ID: 34904097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One novel pathologic variation in
    Qiu SW; Yuan YY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):820-824. PubMed ID: 31446696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.